Investor Relation

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Next Day Disclosure Returns

Overseas Regulatory Announcement-Announcement in Connection with Tramadol Hydrochloride Sustained-release Tablets Passing the Generic Drugs Consistency Evaluation

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2024

Renewal of Continuing Connected Transaction In Relation To Trademark Licence Agreement

Inside Information Announcement-Entering into Acquisition Letter of Intent in Relation to the  Acquisition of A Company

Poll Results of the Extraordinary General Meeting

Overseas Regulatory Announcement-Announcement in Connection with the Drugs of a Wholly-owned Subsidiary Passing the Generic Drugs Consistency Evaluation

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information